Patrick O'Leary
7PUBLICATIONS
76CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Nov 19, 2025
The Mac1 ADP-ribosylhydrolase is a therapeutic target for SARS-CoV-2.Rahul K Suryawanshi, Priyadarshini Jaishankar, Galen J Correy
|Sep 24, 2024
PARP7 Inhibitors and AHR Agonists Act Synergistically across a Wide Range of Cancer Models.Huadong Chen, Xuxu Gou, Ying Mao
|Aug 16, 2024
The Mac1 ADP-ribosylhydrolase is a Therapeutic Target for SARS-CoV-2.Rahul K Suryawanshi, Priyadarshini Jaishankar, Galen J Correy
|Oct 23, 2022
Resistance to ATR Inhibitors Is Mediated by Loss of the Nonsense-Mediated Decay Factor UPF2.Patrick C O'Leary, Huadong Chen, Yagmur U Doruk
|Aug 24, 2022
RASA2 ablation in T cells boosts antigen sensitivity and long-term function.Julia Carnevale, Eric Shifrut, Nupura Kale
|Apr 19, 2022
A Whole-Genome CRISPR Screen Identifies AHR Loss as a Mechanism of Resistance to a PARP7 Inhibitor.Huadong Chen, Morgan E Diolaiti, Patrick C O'Leary
Pageof 2
Frequent Collaborators
7 joint publications
Morgan E Diolaiti
7 joint publications
Alan Ashworth
5 joint publications
Nevan J Krogan
4 joint publications
Huadong Chen
4 joint publications
Danielle L Swaney
3 joint publications
Minkyu Kim
3 joint publications
Adam R Renslo
3 joint publications
Melanie Ott
3 joint publications
James S Fraser
2 joint publications
Ajda Rojc
